As a leading DNA synthesis company, Synbio Technologies offers a comprehensive package of synthetic genomics services, from simple oligonucleotides and DNA fragments to large and complex genome clusters. Our cutting edge Syno^® 3.0 high-throughput platform is the world’s most advanced next-generation DNA synthesis platform, able to provide affordable synthetic DNA at unprecedented scale.

At Synbio Technologies, our DNA synthesis capacity is empowered by several patented technologies. Industry-Leading NG^TM Codon can help customers redesign and enhance the efficiency of the genes to achieve superior gene expression. Syno® Assembly is truly one-of-a-kind technology, working in tandem with our Syno^® 2.0 platform to ensure the delivery of affordable, error-free sequences.

In addition, Synbio Technologies is building up its first integrated Syno GPS (Genotype, Phenotype and Synotype) system, aiming to streamline translation or reverse translation between “Genotype” and “Phenotype” through our proprietary “Synotype” platform. Our company’s scientific capabilities encompass areas such as molecular biology and bio-pharmaceutical research, precision medicine, biotechnology, molecular breeding, and biofuel production.

Synbio Technologies, a DNA synthesis company devote to next generation DNA synthesis, provides a variety of synthetic genomic options to advance your research, including primer synthesis, gene synthesis, metabolic pathway synthesis, gene cluster synthesis, CRISPR-Cas9 service, Sanger sequencing, and NGS services.